Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Sales: What’s Changing, What Isn’t—and What It Means for You

Does sales performance matter to you - whether you sell, lead sales teams or are responsible for business performance?  

There’s a lot of noise about how sales is changing, but it can be hard to know what’s real and what it means for you, your team, and your business. It’s true that B2B sales is always evolving, but not always in the ways we might think or the hype suggests. Join us for a practical session that cuts through the noise to explore what’s really changing—and, as importantly, what isn’t.

Scientist I

We are Alloy Therapeutics—a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics. The company facilitates affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma.

Biotechgate Digital Partnering

Virtual business development & licensing event.

Biotechgate Digital Partnering is designed to support the business development & licensing of Pharma, Biotech, Medtech and Digital Health companies. Join five days of virtual partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings in our business forum.

*One Nucleus members can upgrade to Premium access for free. Please contact [email protected] for the details.

Webinar: Accelerating ADC Discovery through Strategically Integrated Chemistry, Biology, and DMPK

Antibody-drug conjugates (ADCs) hold great promise in targeted therapies, yet their development in the drug discovery phase involves complex challenges in chemistry, biology, and DMPK. This webinar demonstrates how integrated strategies help overcome these hurdles and support informed preclinical decisions.

BioDuro Webinar: Accelerating PROTACs and RIPTACs Programs: From Synthesis to In Vitro Profiling

Want to speed up early discovery of PROTACs and RIPTACs? These heterobifunctional molecules move beyond classical occupancy-driven inhibition to event-driven modulation of protein function, enabling therapeutic targeting of proteins that were previously considered undruggable. This webinar demonstrates how chemical synthesis and in vitro profiling can be combined to rapidly generate, optimize, and advance these molecules in early discovery programs.

Policy and Public Affairs Manager

Applications are invited for a Policy and Public Affairs Manager to join the Communications team at the Quadram Institute, based in Norwich, UK.

Background:

The Policy and Public Affairs Manager will have a critical role in ensuring the impact of the Institute’s work on food, nutrition and human health, is effectively represented to policymakers, funders, government departments, and our external partners.

The role:

Senior Biobank Scientist

Human Biological Samples (HBS) sit at the heart of clinical research, enabling the discovery, development and delivery of new treatments and diagnostics. As ethically sensitive materials, they underpin every clinical trial and demand rigorous handling and oversight. The Senior Biobank Scientist maintains and develops the HBS inventory in line with Good Clinical Practice (GCP), global standards and standard operating procedures (SOPs), ensuring samples are received, logged, stored, tracked, despatched, returned and disposed of appropriately.

Head of Philanthropy

We are now building upon this success and have launched a new, significant fundraising campaign. This campaign will help drive further transformational growth, from income across major donors, trusts and foundations, and corporate partners. Ultimately, it will help us fund cutting-edge research that will bring forward the day when we can diagnose, treat and prevent dementia.

Subscribe to